Syndax Pharmaceuticals Inc (SNDX)
20.34
-0.93%
Syndax Pharmaceuticals Inc (SNDX) is currently trading at $20.34. This represents a loss of 0.93% from the previous session. With a market capitalization of $1.77B, SNDX is a key component of the Health Care sector. Investors looking to trade SNDX should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade SNDX commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Syndax Pharmaceuticals Inc (SNDX) shows a bearish trend. Analysts are watching the 20.78 level closely.
Fundamentals
Mkt Cap1.77B
P/E Ratio0.0000
Volume321,124
60-Day Technical Chart
Advanced Charting
Need more indicators for SNDX? Use the world's #1 platform.
Open SNDX on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $20
| Metric |
SNDX -0.93% |
SOFI +4.21% |
BMNR +13.73% |
HPQ +1.82% |
|---|---|---|---|---|
| Price | $20.34 | $19.45 | $22.13 | $18.43 |
| Mkt Cap | $1.77B | $24.83B | $10.03B | $16.92B |
| - | View → | View → | View → |
Latest Headlines
Biotech CEO plans three March investor Q&As in Boston and Miami
Stock Titan • Feb 23, 2026
Syndax to Announce Fourth Quarter and Full Year 2025
GlobeNewswire • Feb 19, 2026
Syndax Pharmaceuticals' Early Launch Success Signals Continued Growth Into 2026 (NASDAQ:SNDX)
Seeking Alpha • Feb 12, 2026
Syndax Pharmaceuticals CEO sells $152,835 in SNDX stock
Investing.com • Feb 6, 2026
Syndax Pharmaceuticals (SNDX) Is Up 15.8% After Revenue Surges in Q2 2025 Results Has Sentiment Shifted?
Yahoo Finance • Aug 14, 2025
● Gemini Agentic AI Analyst Insight for SNDX
Market Education
- Large Cap at Lowest Price Apr 9, 2024
- Trump’s New Tariffs Could Push Up Kitchen Renovation Costs Sep 26, 2025
- AI and the Stock Market: How Artificial Intelligence Is Driving a New Bull Run Sep 26, 2025
External Research